Raphael Pharmaceutical Stock Fundamentals
| RAPH Stock | 0.26 0.00 0.00% |
Raphael Pharmaceutical fundamentals help investors to digest information that contributes to Raphael Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Raphael OTC Stock. The fundamental analysis module provides a way to measure Raphael Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Raphael Pharmaceutical otc stock.
Raphael |
Raphael Pharmaceutical OTC Stock Return On Asset Analysis
Raphael Pharmaceutical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Raphael Pharmaceutical Return On Asset | -19.04 |
Most of Raphael Pharmaceutical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Raphael Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Raphael Pharmaceutical has a Return On Asset of -19.0369. This is much lower than that of the sector and significantly lower than that of the Return On Asset industry. The return on asset for all United States stocks is notably higher than that of the company.
Raphael Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Raphael Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Raphael Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Raphael Pharmaceutical competition to find correlations between indicators driving Raphael Pharmaceutical's intrinsic value. More Info.Raphael Pharmaceutical is rated below average in return on asset category among its peers. It also is rated below average in shares outstanding category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Raphael Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Raphael Pharmaceutical's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Raphael Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Raphael Pharmaceutical's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Raphael Pharmaceutical could also be used in its relative valuation, which is a method of valuing Raphael Pharmaceutical by comparing valuation metrics of similar companies.Raphael Pharmaceutical is currently under evaluation in return on asset category among its peers.
Raphael Fundamentals
| Return On Asset | -19.04 | |||
| Shares Outstanding | 15.62 M | |||
| EBITDA | (1.63 B) | |||
| Net Income | (1.62 B) | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (1.42 M) | |||
| Market Capitalization | 17.19 M | |||
| Total Asset | 422 K | |||
| Net Asset | 422 K |
About Raphael Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Raphael Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Raphael Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Raphael Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Raphael OTC Stock
Raphael Pharmaceutical financial ratios help investors to determine whether Raphael OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Raphael with respect to the benefits of owning Raphael Pharmaceutical security.